This section is not available in the published analysis.
Pharvaris: Audience
Pharvaris is dedicated to developing novel oral alternatives that enhance the standard of care for individuals living with hereditary angioedema (HAE).
Pharvaris is dedicated to developing novel oral alternatives that enhance the standard of care for individuals living with hereditary angioedema (HAE).
This section is not available in the published analysis.